GEN Exclusives

More »

Best Science Apps

More »
Sep 01, 2013 (Vol. 33, No. 15)

Nature of Code

URL:bit.ly/19EI6KE
  • Most simulations are interactive (respond to user input)
  • More detailed descriptions of the phenomena would be useful
Platform: iPad/iPhone  
Cost: Free

Daniel Shiffman’s book entitled, The Nature of Code, discusses how the open source programming language Processing can be used to create computer simulations of natural systems. Keeping with the open source spirit, the entire text of the book is freely available at the book’s website (natureofcode.com). If you’re not feeling up to reading the entire book, the accompanying app for the iPad/iPhone is a great introduction to some of the mathematical concepts and systems found in the natural world. The app includes interactive simulations of these concepts/systems, which are organized into eight categories: randomness, vectors and forces, oscillation, particle systems, triangulation, hair, evolution, and steering. Example simulations include one in which users watch as a tank full of “beings” procreate when they touch (an example of evolution), as well as a simulation of wave addition in which users can drag their fingers to change the amplitude and frequency of one of the waves.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?